Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
-
New drug shows promise for lupus kidney disease in early trial
Disease control Not yet recruitingThis study tests a new drug, SIM0278, in 60 adults with active lupus nephritis, a kidney disease caused by lupus. Participants will receive either SIM0278 or a placebo, and researchers will check if the drug helps improve kidney function over 52 weeks. The goal is to see if SIM02…
Phase: PHASE2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Healthy volunteers test new remdesivir formulation for better absorption
Knowledge-focused Not yet recruitingThis study tests two different versions of a deuterated remdesivir oral suspension in 48 healthy Chinese adults to see how well each is absorbed. Participants will receive both forms in a random order. The goal is to find out if the new formulation works as well as the original, …
Phase: PHASE1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC